President Donald Trump’s deals with pharmaceutical companies are likely to have only a limited impact on Americans’ drug spending, experts say. President Donald Trump’s deals with pharmaceutical companies are likely to have only a limited impact on Americans’ drug spending, experts say.
Trump has announced deals with drugmakers to cut costs. Will they save people money?Trump has announced deals with drugmakers to cut costs. Will they save people money?

